UNSPSC 85272101: Diagnosis of mental and behavioral disorders due to use of cannabinoids amnesic syndrome

This classification denotes the group of activities that yields a diagnosis of Mental and behavioral disorders due to use of cannabinoids on the acute intoxication. Mental and behavioral disorders due to use of cannabinoids on the acute intoxication is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code F12. 0

UNSPSC 85272101 Diagnosis of mental and behavioral disorders due to use of cannabinoids amnesic syndrome is a Commodity code that shows little relevant recent activity. The three most recent state and local contract opportunities tagged to this code — a diagnostic imaging PACS system procurement, special education contracted services, and temporary health professional staffing — bear no substantive connection to the code's nominal scope of cannabinoid-related mental health diagnosis. The mismatch suggests either miscoding by the issuing jurisdictions or a fundamental misalignment between the code's clinical intent and actual purchasing practice under this identifier.

No state and local procurement activity directly related to diagnosis of cannabis-use-disorder or amnesic syndrome services appears in the recent opportunities block. If your firm pursues this code, verify the actual scope through direct contact with issuing agencies before investing in qualification or proposal work, as the tagging inconsistency creates substantial uncertainty about what services are actually being sought.